U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07318103) titled 'Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention' on Nov. 21, 2025.
Brief Summary: Phase II clinical study of HRS-9057 injection in patients with heart failure-induced fluid retention
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Fluid Retention Caused by Heart Failure
Intervention:
DRUG: HRS-9057 injection set
HRS-9057 injection set
DRUG: 5% Glucose Injection
5% Glucose Injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Disclaimer: Curated by HT Syndication....